Immunocore (NASDAQ:IMCR) Research Coverage Started at Robert W. Baird
Robert W. Baird began coverage on shares of Immunocore (NASDAQ:IMCR – Free Report) in a research report released on Tuesday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $84.00 price target on the stock. A number of other research firms have also commented on IMCR. Canaccord Genuity Group began coverage on Immunocore […]
More Stories
InterCure (NASDAQ:INCR) Stock Price Up 1.9% – What’s Next?
InterCure Ltd. (NASDAQ:INCR – Get Free Report) shares were up 1.9% during mid-day trading on Wednesday . The company traded...
Brookfield Property Partners (NASDAQ:BPYPP) Shares Up 0.6% – Should You Buy?
Brookfield Property Partners L.P. (NASDAQ:BPYPP – Get Free Report) shares shot up 0.6% during mid-day trading on Wednesday . The...
Advance Auto Parts (NYSE:AAP) Stock Rating Upgraded by Redburn Atlantic
Advance Auto Parts (NYSE:AAP – Get Free Report) was upgraded by investment analysts at Redburn Atlantic from a “sell” rating...
Splash Beverage Group (NYSEAMERICAN:SBEV) Stock Price Down 5.1% – Here’s What Happened
Splash Beverage Group, Inc. (NYSEAMERICAN:SBEV – Get Free Report) fell 5.1% during mid-day trading on Wednesday . The stock traded...
Integrated Rail and Resources Acquisition (NYSE:IRRX) Stock Price Up 12.6% – Still a Buy?
Integrated Rail and Resources Acquisition Corp. (NYSE:IRRX – Get Free Report) shares rose 12.6% on Wednesday . The company traded...
Wells Fargo & Company Upgrades Cencora (NYSE:COR) to Overweight
Cencora (NYSE:COR – Get Free Report) was upgraded by equities research analysts at Wells Fargo & Company from an “equal...